PTC Therapeutics Historical PE Ratio image   This PTCT PE ratio history page last updated 4/12/2024
PTC Therapeutics Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
2/29/2024
28.19-0.24-0.96NA
Q3 2023
10/26/2023
23.95-1.76-7.04NA
Q2 2023
8/3/2023
40.32-1.48-5.92NA
Q1 2023
4/27/2023
52.64-1.88-7.52NA
Q4 2022
2/21/2023
44.72-1.89-7.56NA
Q3 2022
10/27/2022
44.59-1.53-6.12NA
Q2 2022
8/4/2022
49.23-2.13-8.52NA
Q1 2022
5/3/2022
35.76-1.78-7.12NA
Q4 2021
2/22/2022
38.45-2.03-8.12NA
Q3 2021
10/28/2021
36.44-1.89-7.56NA
Q2 2021
7/29/2021
38.24-1.68-6.72NA
Q1 2021
5/4/2021
38.47-1.83-7.32NA
Q4 2020
2/25/2021
55.19-1.08-4.32NA
Q3 2020
10/29/2020
53.89-1.03-4.12NA
Q2 2020
8/5/2020
48.97-2.62-10.48NA
Q1 2020
4/30/2020
50.92-1.81-7.24NA
Q4 2019
3/2/2020
54.93-1.37-5.48NA
Q3 2019
10/29/2019
39.31-1.06-4.24NA
Q2 2019
8/6/2019
44.75-0.75-3.00NA
Q1 2019
5/2/2019
37.38-1.29-5.16NA
Q4 2018
2/28/2019
34.54-0.58-2.32NA
Q3 2018
11/5/2018
37.90-1.06-4.24NA
Q2 2018
8/7/2018
38.29-0.21-0.84NA
Q1 2018
5/9/2018
30.74-0.46-1.84NA
Q4 2017
3/6/2018
26.840.030.12223.7
Q3 2017
11/2/2017
17.85-0.82-3.28NA
Q2 2017
8/8/2017
19.10-0.44-1.76NA
Q1 2017
5/8/2017
10.79-0.85-3.40NA
Q4 2016
3/16/2017
8.84-0.78-3.12NA
Q3 2016
11/2/2016
6.25-1.03-4.12NA
Q2 2016
8/4/2016
6.09-1.14-4.56NA
Q1 2016
5/5/2016
6.88-1.18-4.72NA
Q4 2015
2/29/2016
7.98-1.50-6.00NA
Q3 2015
11/9/2015
27.46-1.27-5.08NA
Q2 2015
7/30/2015
50.74-1.14-4.56NA
Q1 2015
5/4/2015
60.84-1.15-4.60NA
Q4 2014
2/27/2015
71.33-0.84-3.36NA
Q3 2014
11/6/2014
42.17-0.93-3.72NA
Q2 2014
8/7/2014
27.38-0.86-3.44NA
Q1 2014
5/6/2014
17.44-0.58-2.32NA
Q4 2013
3/6/2014
33.38-0.75-3.00NA
Q3 2013
11/14/2013
15.87-0.19-0.76NA
PTC Therapeutics PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
2/29/2024
28.19-0.24-5.36NA
Q3 2023
10/26/2023
23.95-1.76-7.01NA
Q2 2023
8/3/2023
40.32-1.48-6.78NA
Q1 2023
4/27/2023
52.64-1.88-7.43NA
Q4 2022
2/21/2023
44.72-1.89-7.33NA
Q3 2022
10/27/2022
44.59-1.53-7.47NA
Q2 2022
8/4/2022
49.23-2.13-7.83NA
Q1 2022
5/3/2022
35.76-1.78-7.38NA
Q4 2021
2/22/2022
38.45-2.03-7.43NA
Q3 2021
10/28/2021
36.44-1.89-6.48NA
Q2 2021
7/29/2021
38.24-1.68-5.62NA
Q1 2021
5/4/2021
38.47-1.83-6.56NA
Q4 2020
2/25/2021
55.19-1.08-6.54NA
Q3 2020
10/29/2020
53.89-1.03-6.83NA
Q2 2020
8/5/2020
48.97-2.62-6.86NA
Q1 2020
4/30/2020
50.92-1.81-4.99NA
Q4 2019
3/2/2020
54.93-1.37-4.47NA
Q3 2019
10/29/2019
39.31-1.06-3.68NA
Q2 2019
8/6/2019
44.75-0.75-3.68NA
Q1 2019
5/2/2019
37.38-1.29-3.14NA
Q4 2018
2/28/2019
34.54-0.58-2.31NA
Q3 2018
11/5/2018
37.90-1.06-1.70NA
Q2 2018
8/7/2018
38.29-0.21-1.46NA
Q1 2018
5/9/2018
30.74-0.46-1.69NA
Q4 2017
3/6/2018
26.840.03-2.08NA
Q3 2017
11/2/2017
17.85-0.82-2.89NA
Q2 2017
8/8/2017
19.10-0.44-3.10NA
Q1 2017
5/8/2017
10.79-0.85-3.80NA
Q4 2016
3/16/2017
8.84-0.78-4.13NA
Q3 2016
11/2/2016
6.25-1.03-4.85NA
Q2 2016
8/4/2016
6.09-1.14-5.09NA
Q1 2016
5/5/2016
6.88-1.18-5.09NA
Q4 2015
2/29/2016
7.98-1.50-5.06NA
Q3 2015
11/9/2015
27.46-1.27-4.40NA
Q2 2015
7/30/2015
50.74-1.14-4.06NA
Q1 2015
5/4/2015
60.84-1.15-3.78NA
Q4 2014
2/27/2015
71.33-0.84-3.21NA
Q3 2014
11/6/2014
42.17-0.93-3.12NA
Q2 2014
8/7/2014
27.38-0.86-2.38NA
Q1 2014
5/6/2014
17.44-0.58NANA
Q4 2013
3/6/2014
33.38-0.75NANA
Q3 2013
11/14/2013
15.87-0.19NANA
Quotes delayed 20 minutes

Email EnvelopeFree PTCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
PTC Therapeutics (PTCT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PTE PE Ratio History
PTGX PE Ratio History
PTIX PE Ratio History
PTPI PE Ratio History
PULM PE Ratio History
PYXS PE Ratio History
QDEL PE Ratio History
QLGN PE Ratio History
QNCX PE Ratio History
QTRX PE Ratio History
How should the PTCT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like PTC Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PTCT Historical PE Ratio page.

What is the average historical PE for PTCT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PTCT historical PE ratio using the annualized quarterly earnings method works out to 223.7.

What is the average historical PE for PTCT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PTCT historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the PTC Therapeutics Historical PE Ratio information for PTC Therapeutics' stock. The average PTCT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 223.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PTCT historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PTCT historical PE result, against the recent PE: when this page was posted on 4/11/2024, the most recent closing price for PTCT had been 27.40, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent PTCT PE on 4/11/2024 based on annualized quarterly EPS was 228.3. Based on PTCT's history, that recent PE is elevated relative to the historical average, with the recent PE 2.1% higher than the historical average PE across our data set for PTC Therapeutics.

For self directed investors doing their due diligence on PTCT or any other given stock, valuation analysis for PTCT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate PTC Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PTCT. Thanks for visiting, and the next time you need to research PTCT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of BTX, FPAC Videos, MIK Insider Buying.

 

PTC Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.